Discover the new UrgoTul Absorb Border!
Principle
UrgoTul is the first range of dressings to benefit from the exclusive TLC technology (Technology Lipido-Colloid healing matrix). It combines efficacy, tolerance and acceptability for the optimal healing of wounds regardless of exudate level. The overall objective being to optimise wound healing.
Mode of action
When in contact with wound exudate, Urgotul dressings gel and create a moist environment. UrgoTul dressings stimulate fibroblast proliferation, ensures non-adherence and pain-free dressing changes which promotes the healing process.
TLC technology
Indications
Wounds in the epithelialization stage (burns, abrasions, traumatic wounds, post-operative wounds, leg ulcers, pressure ulcers, diabetic foot ulcers, epidermolysis bullosa).
Contra-indications
None.
Key benefits
- Optimises wound healing
- Ensures pain-free and atraumatic dressing change
- Promotes fibroblasts proliferation
Range
Clinical evidence
For a review of the clinical evidence for TLC dressings please click here